Results 11 to 20 of about 20,101 (185)

Hematological Predictors of Impaired Postpartum Uterine Involution in Thrombophilia: A Multivariate Analysis [PDF]

open access: yesDiagnostics
Background: Although thrombophilia represents a major risk factor for adverse maternal outcomes, particularly in the postpartum period, methods for its systematic screening remain costly and limited.
Loredana Toma   +8 more
doaj   +2 more sources

Identification of Prothrombin Belgrade Variant in a Mexican–American Family with Recurrent Deep Vein Thrombosis [PDF]

open access: yesTH Open
A rare prothrombin variant (c.1787G > A, p.Arg596Gln), also known as the prothrombin Belgrade variant, has been associated with an increased predisposition to thrombosis through resistance to antithrombin.
Émile Moura Coelho da Silva   +2 more
doaj   +2 more sources

Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care

open access: yesJournal of Aging Research, 2011
Introduction. Advances in hemophilia care and treatment have led to increases in the life expectancy among hemophiliacs. As a result, persons with hemophilia are reaching an older age and experiencing various age-related health conditions never seen ...
Aroub A. Khleif   +3 more
doaj   +1 more source

Thrombophilia in hyperhomocysteinemia [PDF]

open access: yesInternational Journal of Emergency Medicine, 2010
A 23-year-old otherwise healthy male presented with development of painful blackish discoloration of the right thumb and index finger and of the right big toe and area over the ankle (Figs. 1 and ​and2),2), as well as painful swelling of both lower limbs, especially on the right side (Fig. 3). Homans′sign was present bilaterally.
Sharma, Vishal   +4 more
openaire   +2 more sources

Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization

open access: yesFrontiers in Endocrinology, 2020
IntroductionObesity is associated with a higher risk of abortion in women undergoing in vitro fertilization (IVF). Whether thrombophilia amplifies this risk is currently unclear.
Matteo Candeloro   +8 more
doaj   +1 more source

Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing? – a cohort study and systematic review of the literature

open access: yesBMJ Open, 2022
Objective There are numerous studies reporting a disproportionally high prevalence of thrombophilia in women with a history of recurrent miscarriage (RM), which has led to overdiagnosis and treatment without an improvement in clinical outcomes.
Hassan Shehata   +7 more
doaj   +1 more source

Thrombophilia identified as a risk factor for thrombogenesis in cancer patients

open access: yesАкушерство, гинекология и репродукция, 2021
Aim: to assess a rate and range of genetic and acquired thrombophilia in onco-gynecologic patients with ovarian cancer, uterine corpus cancer and cervical cancer.Materials and Мethods.
A. V. Vorobev   +4 more
doaj   +1 more source

Features of pregnancy course in patients with thrombophilia and abnormal placenta location

open access: yesАкушерство, гинекология и репродукция, 2023
Aim: to identify inherited and acquired thrombophilia as well as features of pregnancy course in women with abnormal placenta location.Materials and Methods.
V. B. Zubenko, A. I. Lovkova
doaj   +1 more source

Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Direct oral anticoagulants (DOACs) are widely used in several indications, but data on their efficacy and safety in individuals affected by severe inherited thrombophilia, yet without any personal history of thrombosis, is lacking.
Evelien Krumb, Cedric Hermans
doaj   +1 more source

A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis
Thomas G. Deloughery   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy